Key regions: United Kingdom, Germany, France, South Korea, Italy
The COVID-19 pandemic has affected the world in many ways, including the healthcare industry. Countries around the globe have been racing to develop vaccines to combat the virus. Laos is one of the countries that has been affected by the pandemic, and as a result, the COVID-19 vaccines market in Laos has been developing.
Customer preferences: Laos has a population of around 7 million people, and the majority of them live in rural areas. The country's healthcare system is still developing, and many people do not have access to basic healthcare services. However, the government has been working to improve the healthcare system, and the COVID-19 vaccines have been made available to the public.
Trends in the market: The COVID-19 vaccines market in Laos has been developing as more vaccines become available. The government has been working with international organizations to secure vaccines for the population. The vaccines have been distributed to healthcare workers, the elderly, and people with underlying health conditions. The government has also been working to educate the public about the importance of getting vaccinated.
Local special circumstances: Laos is a landlocked country in Southeast Asia, and it shares borders with Thailand, Cambodia, Vietnam, China, and Myanmar. The country's economy is heavily dependent on agriculture, and the tourism industry has been growing in recent years. However, the pandemic has affected the tourism industry, and the government has been working to diversify the economy.
Underlying macroeconomic factors: Laos is one of the poorest countries in Southeast Asia, and the pandemic has had a significant impact on the economy. The government has been working to provide economic relief to businesses and individuals affected by the pandemic. The COVID-19 vaccines market in Laos is developing as part of the government's efforts to combat the pandemic and revive the economy.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
